Literature DB >> 20812762

Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function.

Hanna Lee1, Nara Shin, Meiying Song, Un-Beom Kang, Jeonghun Yeom, Cheolju Lee, Yeong Hee Ahn, Jong Shin Yoo, Young-Ki Paik, Hoguen Kim.   

Abstract

HMGB1 is a nuclear protein that is overexpressed and secreted in cancer cells. However, little is known about the roles of HMGB1 in the cytoplasm and secretory pathway in cancer cells. To clarify this aspect of HMGB1 function, we fractionated the cytoplasm of HCT116 colon cancer cells and used a proteomic approach to analyze cytoplasmic HMGB1-binding proteins. Pull-down experiments using recombinant HMGB1 protein as bait, followed by mass spectrometry analysis identified 162 interacting proteins. Among them were 74 proteins known to be localized exclusively to the extra-nuclear region, and 60 proteins known to be localized to both nuclear and extranuclear regions. The functions of these binding proteins include involvement in cell-cycle progression, cell proliferation, anti-apoptosis, and angiogenesis. In addition, nine of the identified proteins are related to protein translocation and secretion. These include annexin A2, myosin IC isoform a, myosin-9, and Ras-related protein Rab10, which are involved in unconventional protein secretion. Cytoplasmic HMGB1 was primarily associated with the lysosomal cytosol fraction and was colocalized with the lysosomal marker LAMP1. Our findings suggest that cytoplasmic HMGB1 binds to a number of molecules related to cancer progression and the unconventional secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812762     DOI: 10.1021/pr100386r

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  15 in total

Review 1.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

2.  High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers.

Authors:  Hee Jin Lee; Joo Young Kim; In Hye Song; In Ah Park; Jong Han Yu; Jin-Hee Ahn; Gyungyub Gong
Journal:  Virchows Arch       Date:  2015-10-07       Impact factor: 4.064

Review 3.  HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer.

Authors:  Kim Jun Cheng; Mohammed Abdullah Alshawsh; Elsa Haniffah Mejia Mohamed; Surendran Thavagnanam; Ajantha Sinniah; Zaridatul Aini Ibrahim
Journal:  Cell Oncol (Dordr)       Date:  2019-11-01       Impact factor: 6.730

4.  The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain.

Authors:  Polina Feldman; Michael R Due; Matthew S Ripsch; Rajesh Khanna; Fletcher A White
Journal:  J Neuroinflammation       Date:  2012-07-23       Impact factor: 8.322

5.  Diagnostic significance of serum HMGB1 in colorectal carcinomas.

Authors:  Hanna Lee; Meiying Song; Nara Shin; Chang Hoon Shin; Byung Soh Min; Hyon-Suk Kim; Jong Shin Yoo; Hoguen Kim
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

6.  The Dual Role of HMGB1 in Pancreatic Cancer.

Authors:  Rui Kang; Daolin Tang
Journal:  J Pancreatol       Date:  2018-12

Review 7.  Cytokine Secretion in Macrophages: SNAREs, Rabs, and Membrane Trafficking.

Authors:  Rachael Zoe Murray; Jennifer Lea Stow
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

8.  Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma.

Authors:  Tiansuo Zhao; He Ren; Xiuchao Wang; Pengfei Liu; Fan Yan; Wenna Jiang; Yang Li; Jing Li; John G Gribben; Li Jia; Jihui Hao
Journal:  Oncotarget       Date:  2015-09-29

9.  Global gene expression in endometrium of high and low fertility heifers during the mid-luteal phase of the estrous cycle.

Authors:  Aideen P Killeen; Dermot G Morris; David A Kenny; Michael P Mullen; Michael G Diskin; Sinéad M Waters
Journal:  BMC Genomics       Date:  2014-03-26       Impact factor: 3.969

Review 10.  NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

Authors:  Claudia Cantoni; Leticia Huergo-Zapico; Monica Parodi; Marco Pedrazzi; Maria Cristina Mingari; Alessandro Moretta; Bianca Sparatore; Segundo Gonzalez; Daniel Olive; Cristina Bottino; Roberta Castriconi; Massimo Vitale
Journal:  J Immunol Res       Date:  2016-05-12       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.